Is Stem Cell Therapy Legal in the U.S.? State-by-State Breakdown

Stem cell therapy laws vary dramatically across the United States, with each state taking its own approach to regulating embryonic stem cell (ESC) research, somatic cell nuclear transfer (SCNT), and access to investigational regenerative treatments.

While the FDA oversees stem cell therapies at the federal level, individual state laws often dictate how—and if—certain procedures can be offered or funded locally. The interactive table below breaks down each state’s stance, funding status, and relevant regulations to help patients, researchers, and providers navigate this complex landscape.

⚡️ Note:

For a more detailed review of a particular state law, visit our State Legal Guides page.

————————————————————————————————————————————————————————————————————————————–

U.S. Regenerative Medicine & Stem Cell Law Tracker

Last Updated: May 2026

Legend:
🟢 Expanded Access = State has enacted broader regenerative medicine or individualized treatment pathways.
🔵 FDA-Based = Primarily follows traditional FDA and physician practice frameworks.
🟡 Reviewing = State analysis pending or undergoing legal review.

⚠️ Disclaimer

This guide is for informational purposes only and does not constitute legal or medical advice. Always consult state and federal regulations and a licensed provider before pursuing treatment.